AIHealthcare

Quibim (Quantitative Imaging Biomarkers in Medicine) is a Spanish healthtech company that applies artificial intelligence, machine learning, and cloud computing to medical imaging. Its platform extracts quantitative imaging biomarkers from MRI, CT, PET, and related modalities to support diagnosis, prognosis, treatment planning, clinical research, and drug development. The company focuses primarily on oncology, immunology, neurology, and metabolic disorders, serving hospitals, research institutions, medical-device companies, and biopharmaceutical organizations. Quibim reports more than 170 installations worldwide, including institutions such as Stanford and Mass General Brigham, and has regulatory clearances in the United States, European Union, United Kingdom, and other markets. Its stated market position is as an imaging-biomarker and precision-medicine specialist rather than a general-purpose clinical AI vendor, with commercial and research partnerships involving Philips, Merck KGaA, Novartis, Microsoft, and others.